Seattle Genetics (SGEN) Misses Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Financial Fact:
Income (loss) from operations: -32.41M
Today's EPS Names:
TAYD, PKE, More
Financial Fact:
Income (loss) from operations: -32.41M
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q4 EPS of ($0.39), $0.05 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $105.3 million versus the consensus estimate of $105.02 million.
GUIDANCE:
Seattle Genetics sees FY2017 revenue of $405-445 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rivian reports record Q3 deliveries, beats estimates, shares rise
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Forgent Power Solutions jumps as Bernstein sees massive earnings upside
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
